lobbying_activities: 1410266

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1410266	d966f71d-9f80-4f18-afea-fd1a4be53075	Q2	MEHLMAN CONSULTING, INC.	284950	AMERICAN CLINICAL LABORATORY ASSOCIATION	2013	second_quarter	MED	Health reform law implementation issues including application of medical device tax to clinical laboratory tests and reform of laboratory fee schedule. In-office ancillary services exception to Stark Law. FDA oversight of laboratory-developed tests.	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office	80000		0	0	2013-07-17T14:52:54.263000-04:00